---
figid: PMC4250230__nihms640682f2
figlink: /pmc/articles/PMC4250230/figure/F2/
number: Figure 2
caption: BRAF oncoproteins promote proliferation by constitutively activating the
  MAP kinase pathway. (a) ATP competitive RAF inhibitors (I) disrupt MEK activation
  and prevent proliferation of BRAF-V600E mutated melanomas in a dose dependent manner.
  (b) Wild-type RAF proteins exist largely in an auto-inhibited state. In the context
  of activated RAS, RAF inhibitors stimulate MEK activation at sub-saturating inhibitor
  concentrations by relieving auto-phosphorylation (P) of wild-type RAF, promoting
  RAF dimerization and association with RAS. Saturating inhibitor concentrations prevent
  MEK phosphorylation by blocking all RAF catalysis.
pmcid: PMC4250230
papertitle: 'Targeting RAF kinases for cancer therapy: BRAF mutated melanoma and beyond.'
reftext: Matthew Holderfield, et al. Nat Rev Cancer. ;14(7):455-467.
pmc_ranked_result_index: '151246'
pathway_score: 0.9314048
filename: nihms640682f2.jpg
figtitle: 'Targeting RAF kinases for cancer therapy: BRAF mutated melanoma and beyond.'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4250230__nihms640682f2.html
  '@type': Dataset
  description: BRAF oncoproteins promote proliferation by constitutively activating
    the MAP kinase pathway. (a) ATP competitive RAF inhibitors (I) disrupt MEK activation
    and prevent proliferation of BRAF-V600E mutated melanomas in a dose dependent
    manner. (b) Wild-type RAF proteins exist largely in an auto-inhibited state. In
    the context of activated RAS, RAF inhibitors stimulate MEK activation at sub-saturating
    inhibitor concentrations by relieving auto-phosphorylation (P) of wild-type RAF,
    promoting RAF dimerization and association with RAS. Saturating inhibitor concentrations
    prevent MEK phosphorylation by blocking all RAF catalysis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - ARAF
  - MAPK1
  - NRAS
  - HRAS
  - MAP2K2
  - KRAS
  - BRAF
  - MAPK3
  - RAF1
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals: []
diseases: []
---
